Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vitamin B12 and Folinic Acid Supplementation in Mitochondrial DNA Deletion Syndromes

NCT06186154 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT06186154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06186154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vitamin B12 and Folinic Acid Supplementation in Mitochondrial DNA Deletion Syndromes
Lead sponsor
University of British Columbia
Phase
Phase 1
Overall status
Unknown status
Start date
January 31, 2024
Completion date
March 31, 2025
Enrollment
25 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

macrocytosis, mitochondrial dna deletion